Delpacibart zotadirsen shows promise in DMD treatment By Investing.com
SAN DIEGO - Avidity Biosciences Inc. (NASDAQ:RNA), a biopharmaceutical firm, reported constructive preliminary outcomes from a Part 1/2 medical trial ...
Tag: DMD
Earnings call: Capricor advances DMD therapy, eyes commercialization By Investing.com
Capricor Therapeutics (NASDAQ:) has accomplished a major section within the growth of its cardiac cell remedy, CAP-1002, for Duchenne muscular ...